The Management of Lower Urinary Tract Obstruction in Patients with Advanced Prostate Cancer
DOI:
https://doi.org/10.6000/1927-7229.2015.04.03.2Keywords:
Non-small-cell lung carcinoma, EGFR, wild-type, erlotinib, second-line.Abstract
Objectives: To determine the optimal time to wait for urination ability restoration after urethral catheterization and anti - androgen treatment, in cases of acute urinary retention and advanced prostate cancer.
Methods: We enrolled 26 patients with histologically confirmed prostate cancer after transrectal ultrasound guided biopsy of the prostate and CT or MRI proven advanced stages (T3-T4). We evaluated the dynamic changes of the following factors; IPSS, QoL, Vmax, residual urine, serum concentration of PSA at the following periods; before hormonal treatment, 1, 3 and 6 months after hormonal treatment.
Results: How long we have to wait after urethral catheter insertion and hormonal treatment for voiding ability restoration?
Our data analyses revealed the answer to this question. The dynamic changes of all the parameters (IPSS, QoL, Vmax, PSA) we studied disclosed interesting regularity. The consequent comparative analyses of parameters showed statistically significant changes only 1 month after anti - androgen treatment. These changes indicate that the prostate cancerous process is significantly suppressed within 1 month after hormonal treatment and there is no point to wait more than 1 month.
Conclusion: Analyzing our data we obtained versatile evidence, that in advanced prostate cancer and acute urinary retention cases the optimal time to wait for sufficient voiding is 1 month period after permanent catheter insertion and anti - androgen treatment.
References
Matveev VB. Screening of prostate cancer. Is it needed? Russian experience. Arch Ital Urol Androl 2006; 78(4): 149-51.
Varenhorst E, Alund G. Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment. Urology 1985; 25: 345-56. http://dx.doi.org/10.1016/0090-4295(85)90485-6
Sehgal A, Mandhani A, Gupta N, Dubey D, Srivastava A, Kapoor R, Kumar A. Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted? J Endourol 2005; 19(5): 546-9. http://dx.doi.org/10.1089/end.2005.19.546
Mommsen S, Petersen L. Transurethral catheter removal after bilateral orchiectomy for prostatic carcinoma associated with acute urinary retention. Scand J Urol Nephrol 1994; 28(4): 401-4. http://dx.doi.org/10.3109/00365599409180520
Gleave ME, Goldenberg SL, Jones EC, et al. Optimal duration of neoadjuvant androgen withdrawal therapy before radical prostatectomy in clinically confined prostate cancer. Sem Urol Oncol 1996; 14(suppl 2): 39-47.
Crawford ED, Eisenburger MA, McLeod DG, et al. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 1989; 321: 419-24. http://dx.doi.org/10.1056/NEJM198908173210702
Chute R, Willetts AT, Gens JP. Experiences in the treatment of carcinoma of the prostate with stilbestrol and with castration by the technique of intra-capsular orchidectomy. J Urol 1942; 48: 682.
Vaillancourt L, Tetu B, Fradet Y, et al. Effect of neoadjuvant endocrine therapy (combined androgen blockage) on normal prostate and prostatic carcinoma. J Surg Pathol 1996; 20: 86-93. http://dx.doi.org/10.1097/00000478-199601000-00010
Fleischmann JD, Catalona WJ. Endocrine therapy for bladder outlet obstruction from carcinoma of the prostate. J Urol 1985; 134: 498-500.
Thomas DJ, Balaji VJ, Coptcoat MJ, Abercrombie GF. Acute urinary retention secondary to carcinoma of the prostate. Is initial channel TURP beneficial? J Roy Soc Med 1992; 85(3): 318-19.
Varenhorst E, Alund G. Urethral obstruction secondary to carcinoma of prostate: response to endocrine treatment. Urology 1985; 25: 345-56. http://dx.doi.org/10.1016/0090-4295(85)90485-6
Carpentier PJ, Schroder FH. Transrectal ultrasonography in the followup of prostatic carcinoma patients: a new prognostic parameter? J Urol 1984; 131: 903-5.
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Aradhana Mohan, S.L. Pranitha, S. Arpitha, S.N. Geeta, Sushmitha K. Thomas, Prognostic Factors Affecting the Overall Survival and Disease-Free Survival in Carcinoma Lung Patients Treated with Sequential Chemoradiation and Concurrent Chemoradiation: A Retrospective Study , Journal of Analytical Oncology: Vol. 14 (2025)
- Sergio Vázquez, María José Villanueva, José Luis Fírvida, Begoña Campos, Martín Lázaro, Gerardo Huidobro, María del Carmen Areses, Natalia Fernández, Marta Covela , Joaquín Casal, Erlotinib as Second-Line Therapy for Patients with Advanced Non-Small-Cell Lung Cancer and Wild-Type EGFR Tumors , Journal of Analytical Oncology: Vol. 4 No. 3 (2015)
- Yianzhu Liu, Li Zhang, Neelam Tejpal, Jacek Z. Kubiak, Rafik M. Ghobrial, Xian C. Li , Malgorzata Kloc , TCTP Silencing in Ovarian Cancer Cells Results in Actin Cytoskeleton Remodeling and Motility Increase , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Arunima Ghosh, Karlena Lara-Otero, Marston W. Linehan , Maria J. Merino , Can Mutations in the BAP1 Gene be Detected by Immunohisto-chemistry in Hereditary Kidney Cancers? , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
- Maria Fernanda Evangelista Simões, Clarissa Maria de Cerqueira Mathias, Oddone Freitas Melro Braghiroli, Eldsamira da Silva Mascarenhas Schettini Sobrinho , Subacute Paraneoplastic Cerebellar Degeneration in an Advanced Small Cell Lung Cancer Patient: Case Report and Literature Review , Journal of Analytical Oncology: Vol. 4 No. 2 (2015)
- Fabiola Cabrera-Cedillo, Anabelle Manzo-Sandova, Yolanda Medina-Flores, María Edith Medina-Escutia, Olga Mata-Ruíz, Alfredo Cruz-Orea, Jorge Adrián Garduño-Medina, Jóse Manuel de la Rosa-Vázquez, Eva Ramón-Gallegos, Combination of Anti α-Gal-PpIX Conjugate and Photodynamic Therapy for the Diagnosis and Elimination of HeLa and CaSki Cells , Journal of Analytical Oncology: Vol. 4 No. 3 (2015)
- Pavel Barta, Karl Andersson, Frantisek Trejtnar , Jos Buijs , Exploring Time-Resolved Characterization of the Heterogeneity and Dynamics of Ligand-Receptor Interactions on Living Cells , Journal of Analytical Oncology: Vol. 3 No. 2 (2014)
- Daiki Taniyama, Tsuyoshi Torii, Junichiro Kuga, Yoriko Dodo, Hitomi Tanaka, Yoshimasa Sueda , Kiyomi Taniyama , A Case Report of Visual Disturbance Caused by Thrombosis of the Superior Sagittal Sinus , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Jianwen Lin, Jiali Yang, Jianjun Lu, Xiaoyi Hao, Jiawei Liu, Huali Yan, Huayi Li, Yu Guo, Yong Gu, Quanyong Cheng, Clinical Features of de Novo Lung Neuroendocrine Tumor after Liver Transplantation for Hepatocellular Carcinoma , Journal of Analytical Oncology: Vol. 11 (2022)
- Tanmoy Bhowmik, Ajoy Kumar Biswas, Amrita Sarkar, Partha Pratim Saha, Aparna Gomes, Antony Gomes , Caspase Pathway Activation and Reactive Oxygen Species Generation in Apoptotic Cell Death of Human Leukemic U937 and K562 Cell Line in Response to King Cobra (Ophiophagus hannah) Venom , Journal of Analytical Oncology: Vol. 3 No. 3 (2014)
You may also start an advanced similarity search for this article.